Related Experiment Video
Updated: May 30, 2026
Non-Invasive Compression-Induced Anterior Cruciate Ligament (ACL) Injury and In Vivo Imaging of Protease Activity in Mice
Published on: September 29, 2023
ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis
Priyanka Verma1, Krishna Dalal
1Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
Abstract:
Osteoarthritis (OA) is a progressive disease of the joints characterized by degradation of articular cartilage. Although disease initiation may be multi-factorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction. A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue. Aggrecanase-mediated aggrecan degradation is a significant event in early stage OA. The relative contribution of individual ADAMTS-4 and ADAMTS-5 proteinases to cartilage destruction during OA has not been resolved completely. This review reveals that both ADAMTS-4/ADAMTS-5 are responsible for aggrecan degradation in a human model of OA, and is expected to list down the rational strategies which are being focussed for therapeutic intervention in OA.
Insights
Osteoarthritis involves cartilage breakdown due to aggrecan degradation by ADAMTS-4 and ADAMTS-5 proteinases. This review explores therapeutic strategies targeting these enzymes for osteoarthritis treatment.
Area of Science:
- Biochemistry
- Rheumatology
- Molecular Biology
Background:
- Osteoarthritis (OA) is a degenerative joint disease characterized by articular cartilage degradation.
- Cartilage destruction in OA results from uncontrolled proteolytic extracellular matrix breakdown.
- Aggrecan, a key proteoglycan providing compressive resistance, is degraded by aggrecanases in early OA.
Purpose of the Study:
- To elucidate the specific roles of ADAMTS-4 and ADAMTS-5 proteinases in OA-related cartilage destruction.
- To review current understanding of aggrecan degradation in human OA models.
- To identify rational therapeutic intervention strategies for OA.
Main Methods:
- Review of existing literature on osteoarthritis pathogenesis.
- Analysis of the contribution of ADAMTS-4 and ADAMTS-5 to aggrecan degradation.
- Examination of human OA models to assess enzyme activity.
Main Results:
- Both ADAMTS-4 and ADAMTS-5 are confirmed to be responsible for aggrecan degradation in a human model of OA.
- The study highlights the significant role of these proteinases in the progression of osteoarthritis.
- Identified key enzymatic pathways driving cartilage matrix destruction.
Conclusions:
- ADAMTS-4 and ADAMTS-5 play critical roles in aggrecan degradation during osteoarthritis.
- Targeting these aggrecanases presents a promising therapeutic avenue for OA.
- Further research into these proteinases could lead to effective OA treatments.
